Chronic non-spherocytic haemolytic anaemia due to congenital pyrimidine 5′ nucleotidase deficiency: 25 years later

Best Practice and Research: Clinical Haematology

Volumn 13, Issue 1, 2000, Pages 103-118

  Corrons, Joan Lluis Vives I ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Haemolytic anaemia; Pyrimidine nucleotide metabolism; Red cell enzymes

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; GLUTATHIONE; HEXOSE PHOSPHATE; PYRIMIDINE 5' NUCLEOTIDE NUCLEOSIDASE; PYRIMIDINE NUCLEOTIDE; RIBOSEPHOSPHATE PYROPHOSPHOKINASE;

AUTOSOMAL RECESSIVE INHERITANCE; BASOPHIL; BIOCHEMISTRY; BLOOD TRANSFUSION; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL OBSERVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME DEFICIENCY; FAMILY; GENE MUTATION; GENE TRANSFER; GEOGRAPHIC DISTRIBUTION; HEREDITARY HEMOLYTIC ANEMIA; HETEROZYGOSITY; HEXOSE MONOPHOSPHATE SHUNT; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL; REVIEW; SPLENECTOMY;

EID: 0034429637     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.1999.0060     Document Type: Article

References (88)

1. Erythrocyte disorders of purine and pyrimidine metabolism
2. Enhanced activity of pyrimidine 5′-nucleotidase in rat red blood cells during erythropoiesis
3. Adenosine 3′:5′-cyclic monophosphate (cAMP)-inducible pyrimidine 5′-nucleotidase and pyrimidine nucleotide metabolism of chick embryonic erythrocytes
4. Age-related red cell enzymes in children with transient erythroblastopenia of childhood and with hemolytic anemia
5. Hereditary hemolytic anemia with human erythrocyte pyrimidine 5′-nucleotidase deficiency
6. Characteristics of a pyrimidine-specific 5′nucleotidase in human erythrocytes
7. Some properties of human erythrocyte pyrimidine 5′-nucleotidase
8. Isozymes of rodent 5-prime-nucleotidase: Evidence for two independent structural loci UMPH-1 and UMPH-2
9. Identification of thymidine nucleotidase and deoxyribonucleotidase activities among normal isozymes of 5-prime-nucleotidase in human erythrocytes
10. Isozymes of human erythrocyte pyrimidine 5′ nucleotidase-chromatographic separation and their properties
11. Pyrimidine nucleotidases/phosphotransferases from human erythrocyte
12. Pyrimidine 5′ nucleotidase activity in normal and deficient human lymphoblastoid cells
13. Assignment of the human gene for uridine 5-prime-monophosphate phosphohydrolase (UMPH2) to the long arm of chromosome 17
14. Construction of a genetic map of human chromosome 17 by use of chromosome-mediated gene transfer
15. Isozymes of rodent 5-prime-nucleotidase: Evidence for two independent structural loci UMPH-1 and UMPH-2
16. Identification of thymidine nucleotidase and deoxyribonucleotidase activities among normal isozymes of 5-prime-nucleotidase in human erythrocytes
17. Pyrimidine 5′-nucleotidase deficiency: Improved detection of carriers
18. Studies on human erythrocyte nucleotide metabolism. II. Nonspherocytic hemolytic anemia, high red cell ATP and ribosephosphate pyrophosphokinase (RPK, EC 2.7.61) deficiency
19. Nonspherocytic haemolytic anaemia with increased red cell adenine nucleotides glutathione and basophilic stippling and ribose pyrophosphokinase (RPPK) deficiency. Studies on two new kindreds
20. Effects of low-level lead exposure on pyrimidine 5′-nucleotidase and other erythrocyte enzymes. Possible role of pyrimidine 5′-nucleotidase in the pathogenesis of lead-induced anemia
21. Lead poisoning: Association with hemolytic anemia, basophilic stippling, erythrocyte pyrimidine 5′-nucleotidase deficiency, and intraerythrocytic accumulation of pyrimidines
22. The in vitro effect of 13 metals on the activity of erythrocyte pyrimidine 5′-nucleotidase (P5N)
23. Inhibition of the pentose phosphate shunt by lead: A potential mechanism for hemolysis in lead poisoning
24. First case of pyrimidine 5′ nucleotidase deficiency in a male
25. A family with red cell pyrimidine 5′ nucleotidase deficiency
26. Hereditary hemolytic anemia with erythrocyte pyrimidine 5′-nucleotidase deficiency in Spain. Clinical biological and familial studies
27. Haemolytic anaemia due to erythrocyte pyrimidine 5′-nucleotidase deficiency. Report of the first South African family
28. Erythrocyte pyrimidine 5′ nucleotidase
29. Three cases of hereditary hemolytic anemia with pyrimidine 5′-nucleotidase deficiency in a Japanese family
30. Pyrimidine 5′-nucleotidase deficiency: Studies of five cases in two Japanese families
31. New cases of hemolytic anemia due to red cell pyrimidine 5′ nucleotidase deficiency detected in two Turkish families
32. A case of hemolytic anemia due to erythrocyte pyrimidine 5′ nucleotidase deficiency
33. Additional data from two kindreds with genetically induced deficiences of erythrocyte pyrimidine nucleotides
34. Hereditary haemolytic anaemia due to red cell pyrimidine 5′-nucleotidase deficiency in two Irish families with a note on the benefit of splenectomy
35. Erythrocyte nucleotide pattern in two children in a Norwegian family with pyrimidine 5-prime-nucleotidase deficiency
36. Hemolytic anemia due to pyrimidine 5′ nucleotidase deficiency: Report of eight cases in six families
37. Pyrimidine 5′ nucleotidase deficiency. Description of a new case
38. Hemolytic anemia caused by pyrimidine 5′-nucleotidase (P5N) deficiency 15 years later. Apropos of two new cases of hereditary deficit and another one of lead, poisoning
39. Pyrimidine 5′ nucleotidase deficiency as the congenital cause of nonspherocytic hemolytic anemia
40. Hemolytic anemia caused by pyrimidine 5′ nucleotidase deficiency
41. Erythrocyte pyrimidine 5′ nucleotidase deficiency. Report of two new cases with review of the literature
42. Report of the first case of pyrimidine 5′ nucleotidase deficiency from Kuwait detected by a screening test. A case report
43. Enzymatic diagnosis in non-spherocytic hemolytic anemia
44. Selective accumulation of cytosol CDP-choline and anisoylated erythrocyte defect in chronic hemolysis
45. Identification of cytidine diphosphodiesters in erythrocytes from a patient with pyrimidine nucleotidase deficiency
46. Syndromes with increased red cell glutathione (GSH)
47. Pyrimidine nucleotides do not affect the enzymes of glutathione biosynthesis
48. Erythrocyte-oxidized glutathione transport in pyrimidine 5′-nucleotidase deficiency
49. Pyrimidine nucleoside monophosphate kinase hyperactivity in hereditary erythrocyte pyrimidine 5′-nucleotidase deficiency
50. Red cell metabolism in hereditary pyrimidine 5′-nucleotidase deficiency: Effect of magnesium
51. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte deficiency
52. Hemolytic anemia in hereditary pyrimidine 5′-nucleotidase deficiency: Nucleotide inhibition of G6PD and the pentose phosphate shunt
53. Hemolytic anemia in hereditary pyrimidine 5′-nucleotidase deficiency. II. Effect of pyrimidine nucleotides and their derivatives on glycolytic and pentose phosphate shunt enzyme activity
54. Inhibition of hexose monophosphate shunt in young erythrocytes by pyrimidine nucleotides in hereditary pyrimidine 5′ nucleotidase deficiency
55. Interaction of hemoglobin E and pyrimidine 5′ nucleotidase deficiency
56. The hemoglobin E syndromes
57. Chromatographic analysis of human erythrocyte pyrimidine 5-prime-nucleotidase from five patients with pyrimidine 5-prime-nucleotidase deficiency
58. Hemolytic Anemia in Disorders of Red Cell Metabolism
59. Electron microscopic observation of the red pulp of the spleen in hereditary hemolytic anemia with erythrocyte pyrimidine 5′-nucleotidase deficiency: Evidence for intravascular hemolysis
60. Aplastic crisis due to human B19 parvovirus infection in red cell pyrimidine-5′-nucleotidase deficiency
61. Erythrocyte pyrimidine 5′-nucleotidase activity in workers exposed to lead, mercury or cadmium
62. Studies on the evaluation of exposure to industrial chemicals
63. Red cell pyrimidine 5′-nucleotidase and glutathione in myeloproliferative and lymphoproliferative disorders
64. Characteristics of red cell pyruvate kinase (PK) and pyrimidine 5′ nucleotidase (P5N) abnormalities in acute leukaemia and chronic lymphoid diseases with leukaemic expression
65. Pyrimidine 5′ nucleotidase and several other red cell enzyme activities in beta-thalassaemia trait
66. Pyrimidine 5′-nucleotidase acquired deficiency in beta-thalassemia: Involvement of enzyme-SH groups in the activation process
67. Pyrimidine 5′-nucleotidase acquired deficiency in beta-thalassaemia: Involvement of enzyme-SH groups in the inactivation process
68. Increased susceptibility of microcytic red blood cells to in vitro oxidative stress
69. Recommended screening test for pyrimidine 5′-nucleotidase deficiency. International Committee for Standardization in Haematology
70. A simple rapid radiometric assay for pyrimidine-5′-nucleotidase
71. A radioassay for pyrimidine-5′-nucleotidase activity
72. An improved method for the determination of human erythrocyte pyrimidine 5′-nucleotidase activity
73. Pyrimidine 5′ nucleotidase deficiency. Improved detection of carriers
74. A spectrophotometric method for the assay of pyrimidine 5′-nucleotidase in human erythrocytes
75. A simplified method for determining erythrocyte pyrimidine 5′-nucleotidase (P5N) activity by HPLC and its value in monitoring lead exposure
76. Red cell pyrimidine 5′ nucleotidase deficiency: Determination of nucleotidase activity and nucleotide content using HPLC
77. Detection of pyrimidine 5′nucleotidase deficiency using IH or 3IP-nuclear magnetic resonance
78. Determination of erythrocyte pyrimidine 5′nucleotidase activity by 3IP nuclear magnetic resonance: Comparison of normal controls and multiple sclerosis patients
79. Determination of pyrimidine 5′-nucleotidase (P5N) activity in whole blood as an index of lead exposure
80. Erythrocyte pyrimidine 5′-nucleotidase and deoxynucleotidase isozymes: Metallosensitivity and kinetics
81. Electrophoretic and kinetic studies of human erythrocytes deficient in pyrimidine 5′-nucleotidase
82. Electrophoretic and kinetic studies of a mutant red cell pyrimidine 5′-nucleotidase
83. Kinetic and electrophoretic studies of human erythrocytes deficient in pyrimidine 5′-nucleotidase
84. Electrophoretic and kinetic studies of human erythrocytes deficient in pyrimidine 5′-nucleotidase
85. Three families with hereditary hemolytic anemia and pyrimidine 5′-nucleotidase deficiency: Electrophoretic and kinetic studies
86. Electrophoretic and kinetic studies of a new mutant red cell pyrimidine 5′-nucleotidase
87. Analysis of human erythrocyte 5′-nucleotidases in healthy individuals and a patient deficient in pyrimidine 5′-nucleotidase